Understanding the function of PITX2 in the adult left atrium

A single genetic switch called PITX2 is active in the left atrium of the adult heart, and its malfunction is more strongly linked to atrial fibrillation than any other known genetic change. Atrial fibrillation is the most common heart rhythm disorder, and it raises the risk of stroke, heart failure, and cognitive decline. Despite decades of research, the fundamental mechanisms that trigger and sustain the arrhythmia remain poorly understood. Recent large-scale genomic studies have pointed to the PITX2 gene as the strongest genetic risk factor, but no one knows what PITX2 actually does in the adult heart. This fellowship aims to close that gap by characterising the normal physiological function of PITX2 in the left atrium and identifying the molecular pathways that connect PITX2 dysfunction to atrial fibrillation. This is fundamental science. There is no immediate clinical application. But if the work succeeds, it will reveal the first clear molecular entry point for designing drugs that prevent or treat atrial fibrillation by targeting the root cause rather than just managing symptoms. Understanding PITX2’s role could eventually lead to therapies that reduce stroke risk and hospitalisations for millions of people—without the side effects of current treatments.